|
|
AEterna Zentaris Incorporated - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for AEterna Zentaris Incorporated. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
AEterna Zentaris Incorporated. The Group's principal activity is to develop novel therapeutic treatments, mainly in cancer and endocrinology. The product pipeline includes products ranging from preclinical to marketing stage. Atrium develops and markets active ingredients and fine chemical products in the cosmetics, nutrition, fine chemical and pharmaceutical industries. The Group has operations in Canada, the United States, Europe, Switzerland, the United Kingdom, Netherlands and Japan.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|